Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review
Authors:
- Oliver WarrenOWOliver Warren
- Kaushik MandalKMKaushik Mandal
- Vassilis HadjianastassiouVHVassilis Hadjianastassiou
- Lisa KnowltonLKLisa Knowlton
- Sukhmeet PanesarSPSukhmeet Panesar
- Kokotsakis JohnKJKokotsakis John
- Ara DarziADAra Darzi
- Thanos AthanasiouTAThanos Athanasiou
- 1 February 2007
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 83 (2) , 707-714
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIaJAMA, 2006
- Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic reviewCritical Care Medicine, 2005
- Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvageBritish Journal of Anaesthesia, 2004
- Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomesTransfusion, 2004
- Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trialThe Lancet, 2003
- Efficacy of a Simple Intraoperative Transfusion Algorithm for Nonerythrocyte Component Utilization after Cardiopulmonary BypassAnesthesiology, 2001
- Recombinant Coagulation Factor VIIa: From the Concept to Clinical Application in Hemophilia Treatment in 2000Seminars in Thrombosis and Hemostasis, 2000
- The effect of the administration of recombinant activated factor VII (NovoSeven®) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE studyBlood Coagulation & Fibrinolysis, 2000
- Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coagulation & Fibrinolysis, 2000
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988